We elucidate the mechanism of cell death associated with the increased expression of soluble AZGP1 and report its potential as a predictive biomarker for therapeutic response to 5-fluorouracil treatment, as well as an immune activator in enhancing the efficacy of anti-cancer therapies. Here, AZGP1 is linked to cancer.